Dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

Document first published:
Page updated:
Topic:
,
Publication type:

Dabrafenib is not recommended to be available off-label as a routine commissioning treatment option for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed.

Document

Clinical commissioning policy: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

Clinical commissioning policy: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

  • PDF
  • 196 KB
  • 7 pages

Summary

Published 19 January 2026.

Document

Clinical panel report: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

Clinical panel report: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

  • PDF
  • 150 KB
  • 4 pages

Summary

Published 19 January 2026.

Document

Clinical Priorities Advisory Group summary report: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

Clinical Priorities Advisory Group summary report: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

  • PDF
  • 150 KB
  • 4 pages

Summary

Published 19 January 2026.

Document

Evidence review: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

Evidence review: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

  • PDF
  • 662 KB
  • 52 pages

Summary

Published 19 January 2026.

Document

Engagement report: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

Engagement report: dabrafenib for BRAFV600E mutation positive histiocytic neoplasms where standard care has failed (all ages)

  • PDF
  • 171 KB
  • 4 pages

Summary

Published 19 January 2026.